FDA Announces Approval for Pharmacogenomic Data Submissions Guidance

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to pharmacogenomic data submissions, as outlined in the 'Guidance for Industry-- Pharmacogenomic Data Submissions' document, under the Paperwork Reduction Act of 1995.